27 bari 2023 English-speaking jobs in Piedmont

Locations : Milan, Rome, Turin, Naples, Bari J-18808-Ljbffr #J-18808-Ljbffr ... investing over $3.6 billion annually in R&D, with offices across Italy in Milan, Rome, Turin, Naples, Bari

with over 6,000 employees across Milan, Rome, Turin, Genoa, Bologna, Treviso, Pisa, Naples, Cosenza, Bari

employees in Italy, located in Milan, Rome, Turin, Genoa, Bologna, Treviso, Pisa, Naples, Cosenza, Bari

Ice Cream business, you will work for the Global, leading Ice Cream player with €7.9bn Turn Over in 2023

Hadoop, Hive, HDFS, HBase Experience with Agile methodologies and DevOps principles Location Milano, Bari

The company’s consolidated revenues for fiscal year 2023 (ended March 31, 2024) totalled 8,564.3 billion

recognized as a great place to work by Great Place to Work in 2015, 2016, 2018, 2020, 2021, 2022, and 2023

recognized as a great place to work by Great Place to Work in 2015, 2016, 2018, 2020, 2021, 2022, and 2023

recognized as a great place to work by Great Place to Work in 2015, 2016, 2018, 2020, 2021, 2022, and 2023

recognized as a great place to work by Great Place to Work in 2015, 2016, 2018, 2020, 2021, 2022, and 2023

The company’s consolidated revenues for fiscal year 2023 (ended March 31, 2024) totalled 8,564.3 billion

Location options include Bari, Bologna, Cosenza, Milano, Napoli, Roma, Salerno, Torino, Treviso, Pisa

Location : Milano, Roma, Torino, Pisa, Napoli, Treviso, Cosenza, Genova, Bari, Salerno, Bologna.

Place: Torino or Bari Qualifications: Bachelor’s or Master’s degree in Electrical Engineering, Aerospace

Launched in October 2023, Farmfront Group is Europe’s irrigation expert and a leading global platform

In 2023, we achieved revenues of approximately €33.6 billion.

With over 55 years of heritage, 340,000 team members across more than 50 countries, and 2023 revenues

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023

Born in 2022, Revolv Space started serving customers in 2023.